Tagged with opinion and analysis

Interview: Dominique Giorgi – President, CEPS (Comité Economique des Produits de Santé), France

Pharma Interview: Dominique Giorgi – President, CEPS (Comité Economique des Produits de Santé), France

Pharma The President of CEPS, the French pricing agency, reveals the issues around the launch of the hepatitis C drug Sovaldi in 2014 and of CEPS´ role to ensure that innovative products are available to all patients who are in need of them. The Sovaldi case has focused public attention on the pricing of drugs in…

Interview: Dr. Edgar Torres, Ph.D – President, Escalate Sciences & Escalate Labs, Puerto Rico

pharma Interview: Dr. Edgar Torres, Ph.D – President, Escalate Sciences & Escalate Labs, Puerto Rico

pharma Escalate Sciences is a Puerto Rican specialized science-based consulting firm focused on R&D, tech transfer, process design & improvement, analytical development and characterization. The company also serves different aspects of the life-sciences industry including project management, validation, qualification, statistical analysis, facility start-up, regulatory & compliance, reformulation and testing services. Its…

Interview: Francisco García – Executive Director, PRMA, Puerto Rico

pharma Interview: Francisco García – Executive Director, PRMA, Puerto Rico

pharma Francisco García was appointed as the executive director for the Puerto Rico Manufacturers Association (PRMA) in August 2015. He stresses the importance of developing Puerto Rico’s entrepreneurial talent and startup clusters as his main initiatives. As you have recently taken over as executive director of PRMA, could you outline the…

Interview: Jörg Buck – Executive Director, German – Italian-German Chamber of Commerce, Italy

pharma Interview: Jörg Buck – Executive Director, German – Italian-German Chamber of Commerce, Italy

pharma Jörg Buck, the Executive Director of the Italian-German Chamber of Commerce discusses the close trade relationship which ties the two countries together, how the business environment in Italy is evolving today and the need to keep the momentum in the economic recovery. To start off, having joined the chamber recently,…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page